Key result
In a novel rat aorta stent model, paclitaxel-eluting stents significantly reduced neointimal area compared to bare metal stents at 2 weeks (0.170 vs 0.262 mm2, p<0.05), but showed no significant difference at 4 weeks.
Why the study?
Does a paclitaxel-eluting stent reduce neointimal hyperplasia and affect re-endothelialization compared to a bare metal stent in a rat aorta model?
Does a paclitaxel-eluting stent reduce neointimal hyperplasia and affect re-endothelialization compared to a bare metal stent in a rat aorta model?
This novel rat aorta stent model successfully demonstrates that paclitaxel-eluting stents initially reduce neointimal hyperplasia but delay re-endothelialization and increase thrombus formation compared to bare metal stents.
Answers are grounded in this paper and cite their sources.
Transient benefit in rat model warrants caution against clinical extrapolation; leaves open durability and safety for translational research.
The purpose of our study was to create a novel rat aorta stent implantation model. Stainless steel bare metal stents (BMS) or paclitaxel-eluting stents (PES) were implanted in male Sprague-Dawley rats (BW 400 ± 20 g). Two and four weeks after stent implantation, the aorta were collected, fixed with 2% glutaraldehyde, and cut into two segments. One segment was used for scanning electron microscopy analysis to evaluate re-endothelialization, and the other segment was used to calculate the neointimal area. At 2 weeks after stenting, the appearance of neointimal hyperplasia was less in the PES group than in the BMS group. At 4 weeks after stenting, no significant difference in neointimal hyperplasia was observed between two groups. On the other hand, the PES group showed more thrombus formation and less re-endothelialization compared to the BMS group. This study demonstrated the ability of a novel rat model of aorta stenting via a common carotid artery to measure the efficacy and safety of commercially available drug-eluting stents.
No takes yet. Share an insight, caveat, or question.
Park et al. (2011) studied Aorta stent implantation model (n=12). Paclitaxel-eluting stent (PES) vs. Bare metal stent (BMS) was evaluated on Neointimal area at 2 weeks (mm2) (p=<0.05). In a novel rat aorta stent model, paclitaxel-eluting stents significantly reduced neointimal area compared to bare metal stents at 2 weeks (0.170 vs 0.262 mm2, p<0.05), but showed no significant difference at 4 weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: